Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from MedAdvisor Limited ( (AU:AHE) ) is now available.
Adheris Health Limited has received the A$6.1 million holdback component from the previously announced sale of its Australian and New Zealand business unit to Jonas Software AUS Pty Ltd, taking total consideration received so far from the divestment to A$33.1 million. The transaction also includes an uncapped three‑year earn‑out arrangement, with the first potential payment due around July 2026, and early indications suggest the divested ANZ business is performing in line with expectations, supporting the prospect of further contingent proceeds and strengthening Adheris Health’s financial flexibility following its strategic exit from the ANZ market.
The most recent analyst rating on (AU:AHE) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:AHE Stock Forecast page.
More about MedAdvisor Limited
Adheris Health Limited (ASX: AHE) is a provider of pharmacy-driven patient engagement solutions designed to personalise and simplify the medication journey. Through its cloud-based, AI-enabled THRiV platform, the company enhances pharmacy workflows and patient engagement, serving more than 25,000 pharmacies across the US and reaching over half of the US population.
Average Trading Volume: 1,382,941
Technical Sentiment Signal: Sell
Current Market Cap: A$13.38M
Learn more about AHE stock on TipRanks’ Stock Analysis page.